385 related articles for article (PubMed ID: 18076707)
1. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
[TBL] [Abstract][Full Text] [Related]
2. [Nephrogenic systemic fibrosis].
Breitschaft A; Stahlmann R
Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
[TBL] [Abstract][Full Text] [Related]
3. The impact of NSF on the care of patients with kidney disease.
Abu-Alfa A
J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
[TBL] [Abstract][Full Text] [Related]
4. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
6. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
Andréjak M; Thuillier D; Lok C; Gras-Champel V
Therapie; 2007; 62(2):169-72. PubMed ID: 17582319
[TBL] [Abstract][Full Text] [Related]
7. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
Lim YL; Lee HY; Low SC; Chan LP; Goh NS; Pang SM
Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Thakral C; Abraham JL
J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
[TBL] [Abstract][Full Text] [Related]
9. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
[TBL] [Abstract][Full Text] [Related]
10. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH
Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
Caccetta T; Chan JJ
Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
[TBL] [Abstract][Full Text] [Related]
12. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
Wiedemeyer K; Kutzner H; Abraham JL; Thakral C; Carlson JA; Tran TA; Hausser I; Hartschuh W
Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532
[TBL] [Abstract][Full Text] [Related]
13. [Nephrogenic systemic fibrosis].
Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium and nephrogenic systemic fibrosis: association or causation.
Kurtkoti J; Snow T; Hiremagalur B
Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
[TBL] [Abstract][Full Text] [Related]
15. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
Heinrich M; Uder M
Rofo; 2007 Jun; 179(6):613-7. PubMed ID: 17497597
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
Todd DJ; Kagan A; Chibnik LB; Kay J
Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histological findings in nephrogenic systemic fibrosis.
Cowper SE; Rabach M; Girardi M
Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
High WA; Ayers RA; Chandler J; Zito G; Cowper SE
J Am Acad Dermatol; 2007 Jan; 56(1):21-6. PubMed ID: 17097388
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis--implications for nephrologists.
Saab G; Abu-Alfa A
Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
